If this email is not displayed correctly please click here

Healthcare & Life Sciences

12 February 2020
Katie Lee Canadian Institute for Health Information publishes drug spending statistics

Canada - Smart & Biggar

The Canadian Institute for Health Information recently published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. Of this 2%, three out of five individuals used a drug therapy that cost C$10,000 or more per year (eg, antivirals or biologics for rheumatoid arthritis or Crohn's disease).

Author: Katie Lee
Read more
Joanne van Harmelen Potential for lucrative cannabis industry in South Africa

South Africa - ENSafrica

There have been a number of key developments in South African life sciences law relating to cannabis in recent years, including amendments to the Medicines and Related Substances Act 1965, such that products which contain only cannabidiol – when intended for therapeutic purposes – can now be obtained from a pharmacist by prescription. Further, cannabis-related trademark applications will now be accepted on the condition that the products comply with the standards set by the health minister.

Author: Joanne van Harmelen
Read more

Recent updates

Nancy Pei Life sciences intellectual property: 2019 highlights

Canada - Smart & Biggar

Author: Nancy Pei
Ina vom Feld Recent case law on compulsory licences and use-up periods

Germany - Simmons & Simmons LLP

Authors: Ina vom Feld, Behyad Hozuri
Jonas Löfgren Marketing authorisation holder lacks standing to challenge off-label prescription for unlicensed products

Sweden - Westerberg & Partners Advokatbyrå Ab

Author: Jonas Löfgren